Sun Pharma arm launches plaque psoriasis treatment drug in Japan

In a regulatory filing, Sun Pharmaceutical Industries said its
"wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous
Injection 100 mg Syringe in Japan for the treatment of plaque
psoriasis in adult patients who have an inadequate response to
conventional therapies".

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-arm-launches-plaque-psoriasis-treatment-drug-in-japan/articleshow/78269005.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Politics of Making Poverty Visible in Brazil and Mexico